Next Article in Journal
The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy
Next Article in Special Issue
Brain Monitoring in Critically Neurologically Impaired Patients
Previous Article in Journal
Mobilization of Nuclear Copper by Green Tea Polyphenol Epicatechin-3-Gallate and Subsequent Prooxidant Breakage of Cellular DNA: Implications for Cancer Chemotherapy
Previous Article in Special Issue
Glucocorticoids Protect Neonatal Rat Brain in Model of Hypoxic-Ischemic Encephalopathy (HIE)
Open AccessReview

Stem Cells and Labeling for Spinal Cord Injury

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
Stem Cell Therapies in Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain
National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2, ISCIII, Research Center “Principe Felipe”, c/Eduardo Primo Yúfera 3, 46012 Valencia, Spain
Institute of Experimental Medicine, Department of Neuroscience, Academy of Science of the Czech Republic, Videnská 1083, 142 20 Prague 4, Czech Republic
Neuronal and Tissue Regeneration Laboratory, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain
Spebo Medical, 16000 Leskovac, Serbia
Author to whom correspondence should be addressed.
Academic Editor: Xiaofeng Jia
Int. J. Mol. Sci. 2017, 18(1), 6;
Received: 30 September 2016 / Revised: 9 December 2016 / Accepted: 12 December 2016 / Published: 26 December 2016
(This article belongs to the Special Issue Neurological Injuries’ Monitoring, Tracking and Treatment 2016)
Spinal cord injury (SCI) is a devastating condition that usually results in sudden and long-lasting locomotor and sensory neuron degeneration below the lesion site. During the last two decades, the search for new therapies has been revolutionized with the improved knowledge of stem cell (SC) biology. SCs therapy offers several attractive strategies for spinal cord repair. The transplantation of SCs promotes remyelination, neurite outgrowth and axonal elongation, and activates resident or transplanted progenitor cells across the lesion cavity. However, optimized growth and differentiation protocols along with reliable safety assays should be established prior to the clinical application of SCs. Additionally, the ideal method of SCs labeling for efficient cell tracking after SCI remains a challenging issue that requires further investigation. This review summarizes the current findings on the SCs-based therapeutic strategies, and compares different SCs labeling approaches for SCI. View Full-Text
Keywords: stem cells; spinal cord injury; stem cell labeling stem cells; spinal cord injury; stem cell labeling
Show Figures

Figure 1

MDPI and ACS Style

Gazdic, M.; Volarevic, V.; Arsenijevic, A.; Erceg, S.; Moreno-Manzano, V.; Arsenijevic, N.; Stojkovic, M. Stem Cells and Labeling for Spinal Cord Injury. Int. J. Mol. Sci. 2017, 18, 6.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop